Terconazole
Pricing Report NDC 0591-3197-52

Latest NADAC: $1.24760 per GM · Effective Nov 22, 2017 · Est. package price $24.95 (20 GM)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Terconazole (NDC 0591-3197-52) is $1.24760 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Nov 22, 2017.

As a provided by Actavis Pharma, Inc, this medication is distributed in a 1 TUBE, WITH APPLICATOR in 1 CARTON / 20 g in 1 TUBE, WITH APPLICATOR configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$1.24760
Per GM

Effective Date
Nov 22, 2017
Billable Units
20 GM
Estimated Package Price
$24.95
Data Status
As of Nov 29, 2017
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 TUBE, WITH APPLICATOR in 1 CARTON / 20 g in 1 TUBE, WITH APPLICATOR
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Nov 2013, the NADAC wholesale price for (NDC ) has moved within a range of $1.18241 to $1.48691 per GM. Over this 4 years period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.1824 - $1.4869
Market Volatility
25.75% Variance
Latest Trend
0.90%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Nov 22, 2017 $1.24760 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Oct 18, 2017 $1.25894 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Sep 20, 2017 $1.27296 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Aug 23, 2017 $1.24279 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jul 19, 2017 $1.29713 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jun 21, 2017 $1.30204 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
May 17, 2017 $1.31710 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Apr 19, 2017 $1.32777 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Mar 22, 2017 $1.36175 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Feb 22, 2017 $1.39524 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Jan 18, 2017 $1.37352 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic
Dec 21, 2016 $1.44535 GMC/I - Chain or Independent PharmacyCode 1, 5, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026